Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

368 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Systematic review and meta-analysis of the effects of menopause hormone therapy on cognition.
Andy C, Nerattini M, Jett S, Carlton C, Zarate C, Boneu C, Fauci F, Ajila T, Battista M, Pahlajani S, Christos P, Fink ME, Williams S, Brinton RD, Mosconi L. Andy C, et al. Among authors: christos p. Front Endocrinol (Lausanne). 2024 Mar 4;15:1350318. doi: 10.3389/fendo.2024.1350318. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38501109 Free PMC article.
Author Correction: Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial.
Altorki NK, Walsh ZH, Melms JC, Port JL, Lee BE, Nasar A, Spinelli C, Caprio L, Rogava M, Ho P, Christos PJ, Saxena A, Elemento O, Bhinder B, Ager C, Amin AD, Sanfilippo NJ, Mittal V, Borczuk AC, Formenti SC, Izar B, McGraw TE. Altorki NK, et al. Among authors: christos pj. Nat Commun. 2024 Jan 3;15(1):225. doi: 10.1038/s41467-023-44575-3. Nat Commun. 2024. PMID: 38172131 Free PMC article. No abstract available.
Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial.
Altorki NK, Walsh ZH, Melms JC, Port JL, Lee BE, Nasar A, Spinelli C, Caprio L, Rogava M, Ho P, Christos PJ, Saxena A, Elemento O, Bhinder B, Ager C, Amin AD, Sanfilippo NJ, Mittal V, Borczuk AC, Formenti SC, Izar B, McGraw TE. Altorki NK, et al. Among authors: christos pj. Nat Commun. 2023 Dec 19;14(1):8435. doi: 10.1038/s41467-023-44195-x. Nat Commun. 2023. PMID: 38114518 Free PMC article.
Timing to Surgery and Lymph Node Upstaging in Gastric Cancer: An NCDB Analysis.
Riascos MC, Greenberg JA, Palacardo F, Edelmuth R, Lewis VC, An A, Najah H, Al Asadi H, Safe P, Finnerty BM, Christos PJ, Fahey TJ 3rd, Zarnegar R. Riascos MC, et al. Among authors: christos pj. Ann Surg Oncol. 2024 Mar;31(3):1714-1724. doi: 10.1245/s10434-023-14536-7. Epub 2023 Nov 25. Ann Surg Oncol. 2024. PMID: 38006526
Systematic review and meta-analysis of the effects of menopause hormone therapy on risk of Alzheimer's disease and dementia.
Nerattini M, Jett S, Andy C, Carlton C, Zarate C, Boneu C, Battista M, Pahlajani S, Loeb-Zeitlin S, Havryulik Y, Williams S, Christos P, Fink M, Brinton RD, Mosconi L. Nerattini M, et al. Among authors: christos p. Front Aging Neurosci. 2023 Oct 23;15:1260427. doi: 10.3389/fnagi.2023.1260427. eCollection 2023. Front Aging Neurosci. 2023. PMID: 37937120 Free PMC article.
Chatbot Artificial Intelligence for Genetic Cancer Risk Assessment and Counseling: A Systematic Review and Meta-Analysis.
Webster EM, Ahsan MD, Perez L, Levi SR, Thomas C, Christos P, Hickner A, Hamilton JG, Babagbemi K, Cantillo E, Holcomb K, Chapman-Davis E, Sharaf RN, Frey MK. Webster EM, et al. Among authors: christos p. JCO Clin Cancer Inform. 2023 Sep;7:e2300123. doi: 10.1200/CCI.23.00123. JCO Clin Cancer Inform. 2023. PMID: 37934933 Free article. Review.
368 results